Clinical trial
Prevention and Treatment of Hemodialysis Vascular Access Malfunction
NCT00179192 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention and Treatment of Hemodialysis Vascular Access Malfunction
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- May 31, 1998
- Completion date
- October 31, 2006
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease